Characterizing Autoimmune Disease-associated Diffuse Large B-cell Lymphoma in a SEER –Medicare Cohort

Conclusion In the present retrospective claims-based cohort of older patients with DLBCL, concomitant AI disease was uncommon and was more likely to occur in female DLBCL patients, which likely reflects the greater incidence of AI disease in women. The possibility of lower LRS for SLE patients should be explored in future studies. Micro-Abstract We used the Surveillance, Epidemiology, and End Results (SEER)–Medicare-linked database to characterize the patterns of presentation, treatment, and survival in older diffuse large B-cell lymphoma (DLBCL) patients with concomitant autoimmune disease. DLBCL patients with autoimmune disease were more likely to be female but otherwise did not differ significantly from other DLBCL patients in demographic data, treatment, or clinical outcomes.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research